XML 44 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stockholders' Equity - Schedule of Stock Option Activity (Detail)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2017
USD ($)
$ / shares
shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Number of Shares, Outstanding at December 31, 2016 | shares 1,540
Number of Shares, Exercised | shares (63)
Number of Shares, Forfeited | shares (21)
Number of Shares, Outstanding at March 31, 2017 | shares 1,456
Number of Shares, Exercisable at March 31, 2017 | shares 856
Number of Shares, Vested and expected to vest at March 31, 2017 | shares 1,456
Weighted - Average Exercise Price Per Share, Outstanding, Beginning balance | $ / shares $ 34.35
Weighted - Average Exercise Price Per Share, Exercised | $ / shares 30.15
Weighted - Average Exercise Price Per Share, Forfeited | $ / shares 33.86
Weighted - Average Exercise Price Per Share, Outstanding, Ending balance | $ / shares 34.54
Weighted - Average Exercise Price Per Share, Exercisable at March 31, 2017 | $ / shares 33.80
Weighted - Average Exercise Price Per Share, Vested and expected to vest at March 31, 2017 | $ / shares $ 34.54
Weighted - Average Remaining Contractual Term, Outstanding at March 31, 2017 6 years 3 months 15 days
Weighted - Average Remaining Contractual Term, Exercisable at March 31, 2017 5 years 2 months 5 days
Weighted - Average Remaining Contractual Term, Vested and expected to vest at March 31, 2017 6 years 3 months 15 days
Aggregate Intrinsic Value, Outstanding at March 31, 2017 | $ $ 7,605
Aggregate Intrinsic Value, Exercisable at March 31, 2017 | $ 5,094
Aggregate Intrinsic Value, Vested and expected to vest at March 31, 2017 | $ $ 7,605